International medical cannabis company Akanda Corp. named Dr. Sunny Nayee as its new UK medical director. The appointment of Nayee, a pain treatment expert with direct experience in cannabis therapies, builds upon the company’s partnership with Cellen Life Sciences. At Akanda, Nayee will be responsible for monitoring and improving the overall level of care provided to medical patients in the UK, as well as helping assess expansion into other international markets.
Nayee joins Akanda from the Lyphe Group, a cannabis clinical telehealth and dispensing ecosystem, where he served as medical director. Nayee has been recommending cannabis to his patients since 2019 and currently treats over 1,000 people. Under his leadership at Lyphe, The Medical Cannabis Clinics became the first-ever cannabis clinic to receive a “good” rating from the Care Quality Commission.
